Known side effects (class effects similar to other GLP-1 medications) Gastrointestinal issues (very common): Nausea: 38-43% of participants vs 11% placebo Diarrhea: 33-35% vs 13% placebo Vomiting: 20-21% vs 0% placebo Constipation: 22-25% vs 9% placebo Decreased appetite: 18-19% vs 9% placebo These are expected with incretin-based therapies and typically improve over time as your body adjusts
I confirmed the diagnosis with orthopedic tests called phalens and tinels tests
Peptides operate through various mechanisms, including by stimulating skin cell proliferation, augmenting collagen synthesis, preventing collagen degradation, activating growth factors, and directly inhibiting facial muscle contraction, resulting in diminished wrinkles and improved skin appearance [3]
I have a calendar reminder to listen to this episode every June 7 so I can remember [] Episode 282: Interview with Steve Leuck, PharmD (2024 Pharmacist Authors Series Part 1 of 3) The Pharmacist Authors Series is back for June, July, and August 2024
MB Methylene blue
It's not just about what a compound does , but how effectively and reliably it gets there